159 related articles for article (PubMed ID: 3321308)
1. Critical genetic determinants and molecular events in multistage skin carcinogenesis.
Slaga TJ; O'Connell J; Rotstein J; Patskan G; Morris R; Aldaz CM; Conti CJ
Symp Fundam Cancer Res; 1986; 39():31-44. PubMed ID: 3321308
[TBL] [Abstract][Full Text] [Related]
2. Skin carcinogenesis: characteristics, mechanisms, and prevention.
Slaga TJ; DiGiovanni J; Winberg LD; Budunova IV
Prog Clin Biol Res; 1995; 391():1-20. PubMed ID: 8532708
[TBL] [Abstract][Full Text] [Related]
3. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
4. Functional loss of tumour suppressor genes in multistage chemical carcinogenesis.
Balmain A; Kemp CJ; Burns PA; Stoler AB; Fowlis DJ; Akhurst RJ
Princess Takamatsu Symp; 1991; 22():97-108. PubMed ID: 1844254
[TBL] [Abstract][Full Text] [Related]
5. The mouse skin carcinogenesis model.
Slaga TJ; Budunova IV; Gimenez-Conti IB; Aldaz CM
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):151-6. PubMed ID: 9627710
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
8. Molecular and cellular basis for tumor promotion in mouse skin.
Yuspa SH
Princess Takamatsu Symp; 1983; 14():315-26. PubMed ID: 6394593
[TBL] [Abstract][Full Text] [Related]
9. Biological and molecular aspects of radiation carcinogenesis in mouse skin.
Bowden GT; Jaffe D; Andrews K
Radiat Res; 1990 Mar; 121(3):235-41. PubMed ID: 2315441
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of chemical carcinogenesis in the skin.
Balmain A; Brown K; Akhurst RJ; Fee FM
Br J Cancer Suppl; 1988 Dec; 9():72-5. PubMed ID: 3076069
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
13. Cellular and biochemical changes during multistage skin tumor promotion.
Slaga TJ; Butler AP
Princess Takamatsu Symp; 1983; 14():291-301. PubMed ID: 6394592
[TBL] [Abstract][Full Text] [Related]
14. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
Hansen LA; Spalding JW; French JE; Tennant RW
Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720
[TBL] [Abstract][Full Text] [Related]
15. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
[TBL] [Abstract][Full Text] [Related]
17. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
18. Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis.
Zoumpourlis V; Solakidi S; Papathoma A; Papaevangeliou D
Carcinogenesis; 2003 Jul; 24(7):1159-65. PubMed ID: 12807763
[TBL] [Abstract][Full Text] [Related]
19. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
Tober KL; Cannon RE; Spalding JW; Oberyszyn TM; Parrett ML; Rackoff AI; Oberyszyn AS; Tennant RW; Robertson FM
Biochem Biophys Res Commun; 1998 Jun; 247(3):644-53. PubMed ID: 9647747
[TBL] [Abstract][Full Text] [Related]
20. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
